Kaposi's sarcoma (KS) is a low-grade vascular neoplasm associated with human herpesvirus-8 (HHV-8) infection that develops in 0.1% to 5% of transplant recipients. 1 A recent multicenter Italian survey showed an approximately 100 times greater risk for KS in organ transplant recipients versus the gen
The coexistence of lymphangiosarcoma and kaposi's sarcoma in a renal transplant recipient
β Scribed by Howard M. Studniberg; Jason K. Rivers; Bridget E. Cooke; Ross St C. Barnetson
- Publisher
- John Wiley and Sons
- Year
- 1991
- Tongue
- English
- Weight
- 702 KB
- Volume
- 68
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Kaposi's sarcoma (KS) risk is high in immunosuppressed transplant recipients. KS develops in recipients with preβexisting infection with human herpesvirus 8 (HHVβ8), the causative agent for KS, but it can also occur in recipients infected by donors. The relative importance of these sour
Kaposi's sarcoma (KS) is a common malignancy in patients with acquired immunodeficiency syndrome (AIDS), classically appearing as red to purple plaques containing small papules and nodules. We report our experience with an adolescent orthotopic liver transplant recipient who presented with an unusua
A retrospective study of 53 cases with a tistological diagnosis of Kaposi's sarcoma (KS) reported to The Cancer Registry of Norway during a five year period is presented. Four cases were excluded from the material because further information contradicted the diagnosis of KS. Of the remaining 49 case